Phenotype measures set:   Jaxpheno6   pct_B

ID, description, units MPD:23109   pct_B   splenic B cells (percentage of total viable cells)   [%]
Measures • 8wks    • 16wks
Data set, strains Jaxpheno6   inbred   11 strains     sex: both
Procedure immune cell quantification
Comparisonmultiple cohorts measured at two age timepoints
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Jaxpheno6 - splenic B cells (percentage of total viable cells)





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
age 1 989.7458 989.7458 71.6889 < 0.0001
sex 1 7.5536 7.5536 0.5471 0.4604
strain 5 55650.823 11130.1646 806.1762 < 0.0001
age:sex 1 4.5838 4.5838 0.332 0.5652
age:strain 5 437.6044 87.5209 6.3393 < 0.0001
sex:strain 5 204.5126 40.9025 2.9626 0.0134
age:sex:strain 5 119.1853 23.8371 1.7266 0.1304
Residuals 189 2609.3564 13.8061

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelStrains
tested
SexAge
Jaxpheno6 23109 immune cell quantification (none) splenic B cells (percentage of total viable cells)   [%]   at age age 8wks   pct_B_8 inbred 11 both 8wks
Jaxpheno6 23110 immune cell quantification (none) splenic B cells (percentage of total viable cells)   [%]   at age age 16wks   pct_B_16 inbred 8 both 16wks